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A B S T R A C T
Background: Tularemia is caused by Francisella tularensis and can occasionally establish foodborne
transmission.
Methods: Patients were identiﬁed by active case detection through contact with the treating physicians
and consent for publication was obtained. Clinical data were accumulated through a review of the patient
charts. Serology, culture, and PCR methods were performed for conﬁrmation of the diagnosis.
Case cluster: A 46-year-old patient was hospitalised in the University Hospital Frankfurt (a tertiary care
hospital) for pharyngitis and cervical lymphadenitis with abscess. A diagnosis of tularemia was made
serologically, but treatment with ciproﬂoxacin initially failed. F. tularensis was detected in pus from the
lymph node using a speciﬁc real-time PCR. The use of RD1 PCR led to the identiﬁcation of the subspecies
holarctica. Antibiotic therapy with high-dose ciproﬂoxacin and gentamicin was administered and was
subsequently changed to ciproﬂoxacin and rifampicin. During a must-tasting, ﬁve other individuals
became infected with tularemia by ingestion of contaminated must. All patients required treatment
durations of more than 14 days.
Conclusions: Mechanically harvested agricultural products, such as wine must, can be a source of
infection, probably due to contamination with animal carcasses. The clinical course of tularemia can be
complicated and prolonged and requires differentiated antibiotic treatment.
© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tularemia is a rare infectious disease caused by Francisella
tularensis. There are two major subspecies causing the disease: F.
tularensis subspecies tularensis, mainly described in Northern
America and leading to a more severe form of the disease, and F.
tularensis subspecies holarctica, the most important subtype found
across the whole Northern Hemisphere, usually causing milder
forms of the disease (Gunnell et al., 2016).
In 2016, 41 cases were notiﬁed in Germany (Robert Koch
Institute, 2016a). In Europe, approximately 500 to 1000 cases per
year are reported, despite the fact that tularemia is not a notiﬁable
disease in all European countries (Robert Koch Institute, 2016b).
The disease has shown a re-emergence in Europe since the turn of* Corresponding author at: University Hospital Frankfurt, Internal Medicine II,
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).the century. Tularemia outbreaks have been recorded in Sweden
and Spain (Eliasson et al., 2002; Pérez-Castrillón et al., 2001). In
2005, an airborne epidemic among hare hunters involving 39
patients was reported from Hesse, Germany (Hauri et al., 2010).
Nonetheless, tularemia can still be regarded as a rare infectious
disease.
Six major forms can be classiﬁed on the basis of clinical
manifestations: the glandular form, the ulceroglandular form, the
oropharyngeal form, the typhoidal form, pulmonary tularemia,
and an oculoglandular form (Weber et al., 2012). A Turkish study
reported a therapeutic failure rate of 38% after 1 year despite early
antibiotic treatment (Meric et al., 2008). It is known that in the case
of late diagnosis and inadequate treatment, tularemia caused by F.
tularensis ssp holarctica can have a protracted and severe course
(Lübbert et al., 2009).
F. tularensis is a fastidious bacterium that can infect over 250
different animals. It is mainly found in rodents (e.g., voles) and
lagomorphs (e.g., hares, rabbits) (Santic et al., 2010). German
studies have found the bacterium to be present in 4.92% of trappedciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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in general (Kaysser et al., 2008; Kuehn et al., 2013). Transmission by
direct contact with animals is possible, for example while skinning
them or processing their meat. Thus, hunters and forest workers
are at increased risk of infection (Hauri et al., 2010). Cats may also
be a reservoir, and transmission via cat bites has been described
(Capellan and Fong, 1993).
In the past, direct contamination of drinking water and food
was responsible for infections (Willke et al., 2009; Grunow et al.,
2012). In particular, F. tularensis ssp holarctica has been shown to be
associated with waterborne infections and epidemics (Santic et al.,
2010). The bacterium is able to survive in brackish water, and
deﬁcient tap water chlorination devices have caused epidemics of
oropharyngeal tularemia in Turkey (Aktas et al., 2015; Berrada and
Telford, 2011). Francisella spp are able to persist within amoebae
(Acanthamoeba castellanii) in the same way as other intracellular
bacterial species (e.g. Legionella, Chlamydia, Mycobacterium), which
may explain the persistence of the bacterium in the environment
(El-Etr et al., 2009; Abd et al., 2003). F. tularensis is a very
contagious bacterium, as only 1–10 bacteria are sufﬁcient to cause
infection (Ellis et al., 2002).
Methods
Patient data acquisition
Patients were identiﬁed by active case detection through
contact with the treating physicians and consent for publication
was obtained. Clinical data were accumulated through a review of
the patient charts.
Serology
An ELISA was used for screening and Western blot (WB) for
conﬁrmation of antibodies against F. tularensis lipopolysaccharide
(LPS). Both in-house assays are accredited by DIN EN ISO/IEC
17025:2005 and DIN EN ISO 15189:2014 and have been described
elsewhere (Jenzora et al., 2008). Brieﬂy, a 96-well microtitre plate
(Polysorb, Nunc, Germany) was coated with puriﬁed LPS from the
live vaccine strain as antigen (Micromun, Germany). Bound human
antibodies to F. tularensis LPS were detected by polyvalent or
monovalent goat anti-human IgA, IgM, and IgG horseradish
peroxidase-conjugated secondary antibody (Dianova, Germany)
and subsequent substrate reaction. Serum dilutions starting with
1:500 that revealed an optical density above the validated cut-off
were counted as positive. For the WB, the soluble fraction of
formalin-inactivated live vaccine strain was separated using
sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) and then transferred to polyvinylidene diﬂuoride
(PVDF) membranes (ImmobilonP, Millipore, USA). Using polyva-
lent horseradish peroxidase-conjugated secondary antibodies, the
typical LPS ladder revealed the presence of speciﬁc anti-F.
tularensis antibodies. The ﬁnal results were given after conﬁrma-
tion of the ELISA results by WB: ‘positive’ denoted strong bands,
‘negative’ almost no bands, and ‘borderline’ weak but clearly
visible bands.
Quantitative real-time PCR (qPCR) and subtyping
DNA was extracted from 100 ml pus and blood using the DNeasy
Blood and Tissue Kit according to the manufacturer’s instructions
(Qiagen, Germany). A multiplex real-time PCR (50 nuclease assay)
targeting fopA and tul4 was used to detect F. tularensis DNA in the
investigated samples; this assay is accredited by DIN EN ISO/IEC
17025:2005 and DIN EN ISO 15189:2014 and has been described
elsewhere with some modiﬁcations (Schulze et al., 2016). Primerand probe sequences for the detection of fopA were Ft-fopA-F:
TTGGGCA AATCTAGCAGGTCA; Ft-fopA-R: ATCTGTAGTCAACACTTG
CTTGAACA; and Ft-fopA-TM: FAM-AAGACCACCACCAACATCC-
CAAGCA-BHQ-1. Those for the detection of tul4 were Ft-tul4-F:
AGATTACAATGGCAGGCTCC; Ft-tul4-R: AGCTGTCCACTT ACCGC
TACA; and Ft-tul4-TM: Cy5-TTCTAAGTGCCATGATACAAGCTTCC-
CAA-BHQ- 2. The real-time PCR assays were run in a total volume
of 25 ml including 5 ml sample volume or DNA in duplicate. The
reaction mix components were TaqMan Environmental MasterMix
2.0 (6.25 ml), 10 pmol/ml primers (0.75 ml each) and probes
(0.25 ml each). Ampliﬁcation was performed in an ABI 7500
instrument (Thermo Fisher Scientiﬁc, Germany), each run with an
initial denaturation step at 95 C for 10 min, followed by 40 cycles
of a denaturation step at 95 C for 15 s, and a combined primer
annealing and elongation step at 60 C for 60 s. An internal
extraction and ampliﬁcation control (KoMa) was added (Kirchner
et al., 2010). The detection limit of the qPCR was 10 genome
equivalents (GE)/5 ml DNA in the reaction volume.
F. tularensis subspecies differentiation was performed by
targeting region of difference 1 (RD1) according to protocols
described by Broekhuijsen et al. (2003). The PCR was conducted
using the Dream Taq Green DNA Polymerase (Thermo Fisher
Scientiﬁc, Germany) with 15–100 ng template DNA.
Approaches for pathogen isolation by culture
For isolation of F. tularensis, 100 ml of pus was cultured in 10 ml
medium T (Becker et al., 2016) and directly on CHAB-PASCV
(cysteine heart agar with blood (Difco, Bestbion, Germany) plus
8  104 U/l polymyxin B, 2.5 mg/l amphotericin B, 20 mg/l
sulfamethoxazole, 100 mg/l cycloheximide, 4 mg/l vancomycin)
and on Neisseria Selective Medium Plus (Oxoid, Germany) agar
plates for 3–14 days at 37 C with 5% CO2 for up to 14 days.
Conventional culture media were inoculated as well.
The same procedure was performed for blood samples. The ﬁrst
blood culture at University Hospital Frankfurt was drawn on day
60, when the patient had already received amoxicillin, clindamy-
cin, sultamicillin, co-amoxiclav, doxycycline, and ciproﬂoxacin
consecutively. Samples were transported under biosafety level 3
(BSL3) conditions at room temperature with a maximum delay of
3 h between withdrawal and arrival in the laboratory. Bacterial
culture was performed in a BSL3 laboratory.
Sentinel case and cluster description
Sentinel case
A 46-year-old man attended a wine-tasting in the region of
Rhineland-Palatinate in the west of Germany. He subsequently
suffered a severe fever and general malaise for 5 days and
consulted a doctor 2 days later (day 7). The doctor noted a swollen
lymph node on the left side of the man’s neck and suspected a viral
infection. Another 2 days later (day 9), problems swallowing and
severe tonsillo-pharyngitis developed. Treatment was initiated
with amoxicillin 1000 mg TID for 2 days, which was subsequently
changed to clindamycin (for a timeline see Figure 1).
Serological tests for Epstein–Barr virus showed no evidence of
acute disease. On day 12, the patient was hospitalized for the ﬁrst
time in a tertiary care hospital and was treated intravenously with
sultamicillin and cortisone for 5 days. On discharge he received
amoxicillin–clavulanic acid for another week. At that time, the
tonsillitis had improved and there was no fever, but his lymph
nodes were still enlarged.
Subsequently, the submandibular lymph nodes increased
in size and became heavily inﬂamed. The patient consulted an
ENT clinician and received doxycycline orally (day 24). Serum
Figure 1. Timeline of the clinical course in the sentinel case. The x-axis shows the days after the wine-tasting event. The antibiotic treatment administered is shown in blue.
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the Robert Koch Institute (RKI, Berlin, Germany). Here, anti-
bodies against F. tularensis LPS were identiﬁed. Ciproﬂoxacin
500 mg twice daily was given for 14 days, which initially led to
clinical improvement. However, the lymph node swelling and
inﬂammation increased again and the patient was therefore
admitted to the University Hospital Frankfurt for inpatient
treatment on day 60.
On admission, the patient showed slightly elevated markers of
inﬂammation, including C-reactive protein (CRP) of 1.71 mg/dl
(normal range <0.5 mg/dl) and a leukocyte count of 10.6  109/l
with 1% immature neutrophils, 60% segmented leukocytes, and
10% monocytes. Clinically a large mass of the left neck could be
observed (Figure 2a). A computed tomography (CT) scan of the
neck was performed. Suppurative lymph nodes inﬁltrating the
platysma and different levels of the neck could be seen (Figure 2b).
A puncture was performed on the same day and the purulent
aspirate was sent to the local microbiology department and the
consultant laboratory (RKI, Berlin). A chest X-ray showed no
pulmonary involvement. Oral ciproﬂoxacin was given at 750 mg
twice daily, combined with gentamicin at 3 mg/kg body weight QD
intravenously from day 60.
On day 66, blood samples were found to be positive for F.
tularensis DNA, and Gram stain of the puncture pus showed small,
gram-negative coccoid rods. On day 67, F. tularensis was conﬁrmed
by 16S rDNA-PCR of pus from the lymph node and subsequent
amplicon sequencing. Treponema pallidum serology and Mycobac-
terium tuberculosis complex PCR were performed to investigate
differential diagnoses; both remained negative. A conﬁrmatory
real-time PCR for tul4 and fopA speciﬁc for F. tularensis was
performed on pus at the consultant laboratory. The RD1 PCR
(Broekhuijsen et al., 2003) showed positive ampliﬁcation of F.Figure 2. (a) Image showing the clinical manifestations in the sentinel case. A local lymp
antibiotic treatments. The clinical picture shows day 60 after the onset of symptoms, at ad
lymphadenopathy described above can be seen in the left side of the neck, with a sizetularensis ssp holarctica. Culture of pus over 14 days in rich media
speciﬁc for F. tularensis was unsuccessful.
The abscess was punctured several times under sterile
conditions. A slight clinical improvement could be observed with
the use of these procedures and the antibiotic treatment.
Unfortunately, an isolate of F. tularensis could not be obtained at
any time; furthermore, culture on conventional media was
unsuccessful.
A CT scan of the neck on day 71 showed that the abscess
formation was only decreasing slightly. Therefore, it was decided to
perform surgical drainage. The patient was discharged with oral
antibiotic treatment comprising ciproﬂoxacin 500 mg twice daily
and rifampicin 600 mg QD on the same day. The drain was kept in
place for 9 days and removed on day 80 after the onset of
symptoms. In the meantime, CRP normalized and the clinical
inﬂammation and swelling decreased as well. The patient
recovered and remained well; he was free of symptoms 8 months
after the onset of the disease.
Clinical data in all patients from the cluster
Five other patients were infected during the same wine-tasting
event: three males and two females (Table 1). The patients ranged
in age from 3 to 41 years (as grape must is non-alcoholic, three
children were attending the tasting). The onset of symptoms
occurred between 4 and 24 days after this wine-tasting event.
Clinically, cervical lymphadenopathy and pharyngitis were ob-
served in nearly all patients, accompanied by fever and general
malaise.
Tularemia was proven serologically in all patients. Effective
treatment was conducted with doxycycline and ciproﬂoxacin in
adult patients, and with ciproﬂoxacin monotherapy in the threeh node swelling with massive inﬂammation evolved in this patient despite multiple
mission to the tertiary care centre. (b) CT scan of the neck of the sentinel patient. The
 of 48.24 mm  28.28 mm.
Table 1
Data of all patients in this cluster of tularemia patients.
Patient Age
(years)
Sex Start of
symptoms
(days after
wine
tasting)
Clinical manifestations Diagnosis
of
tularemia
Antibiotic treatment Start of
effective
treatment
(days after
onset of
symptoms)
Resolution of
last
symptoms
(days after
onset of
symptoms)
Cumulative
duration of
treatment
(days)
1
(Sentinel patient)
46 M 6 Lymphadenitis colli
Fever
Malaise
Serology
PCR from
blood and
pus
Amoxicillin; clindamycin; co-amoxiclav;
sultamicillin; doxycyclinea; ciproﬂoxacina;
gentamicina + ciproﬂoxacina;
rifampicina + ciproﬂoxacina
24 More than 76 76
2 41 M 8 Lymphadenitis colli
Pharyngitis
Fever
Diarrhoea
Serology Erythromycin; doxycyclinea;
ciproﬂoxacina
29 42 14
3 39 F 24 Lymphadenitis colli
Pharyngitis
Fever
Serology Clindamycin; cefuroxime;
doxycyclinea; ciproﬂoxacina
13 Approx. 45 14
4 3 F 5 Lymphadenitis colli
Pharyngitis
Fever
Shivering
Serology Cefaclor; ciproﬂoxacina 32 Approx. 23 14
5 10 F 4 Lymphadenitis colli
Pharyngitis
Fever
Malaise
Serology Cefuroxime; ciproﬂoxacina 33 Approx. 24 14
6 11 F 4 Fever
Headache
Malaise
Pharyngitis
Peri-umbilical swelling
Serology Cefaclor; cefuroxime; ciproﬂoxacina 33 Approx. 24 14
M, male; F, female.
a Effective antibiotic treatments.
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45 days; in none of the ﬁve patients did the time to resolution
exceed that of the sentinel patient, whose course of disease is
described above.
Discussion
Tularemia is a very rare zoonotic disease in Central Europe that
has to be suspected if epidemiological risk factors are present. In
the case presented here, a prolonged history of pharyngitis and
lymphadenopathy complicated by septicaemia led to the delayed
or late clinical diagnosis of tularemia by an ENT doctor. The
tularemia was conﬁrmed serologically and later by microscopy and
16SrDNA PCR. Subsequent antibiotic therapy with gentamicin and
ciproﬂoxacin, later changed to rifampicin and ciproﬂoxacin, was
found to be efﬁcient and led to a decrease in symptoms.
The sentinel patient was diagnosed with an oropharyngeal form of
tularemia suggesting oral intake of the infectious agent (Aktas et al.,
2015; Willke et al., 2009; Djordjevic-Spasic et al., 2011). The sentinel
patient presented with cervical lymphadenopathy and suppurative
lymph nodes and this case took a prolonged course despite the initial
treatment, which could be regarded as adequate. However, Francisella
DNA was detectable in the patient’s lymph node material after
treatment with ciproﬂoxacin, which is noteworthy.
In the case presented, the probable source of transmission was
must consumption in a wine area in Rhineland-Palatinate, Germany.
Here the grapes are pressed directly and the juice remains unﬁltered
until it is subjected to further fermentation for the production of
wine and grape juice. The suspected grape must was shown to carry
tularemia DNA and a mechanical harvester was identiﬁed as the
source, as described previously (Burckhardt et al., 2018). The
consumption of fresh must with the highest genomic equivalents
of F. tularensis ssp holarctica was signiﬁcantly associated with
development of the disease. In the past, direct contamination ofdrinking water and food was responsible for infections (Aktas et al.,
2015; Grunow et al., 2012). In particular, F. tularensis ssp holarctica
has been shown to be associated with waterborne infections and
epidemics (Santic et al., 2010). Thus, the use of automatic harvest
machines could have caused contamination of the grape must with
an infectedrodentor lagomorph. This is underlined bythe fact that F.
tularensis is a highly contagious bacterium, as only 1–10 bacteria are
sufﬁcient to cause infection (Ellis et al., 2002).
In the cluster described herein, the treatment of tularemia was
complicated by a prolonged course of the disease and treatment
needed to be very differentiated. For all patients in this cluster, the
time to resolution of symptoms was more than 3 weeks, indicating
that a treatment duration of 14 days (as described, for example, in
the German recommendations of the Robert Koch Institute, 2016b)
might be too short. Other guidelines do recommend a longer
treatment duration of up to 21 days (Dennis et al., 2001). The
duration of anti-infective treatment could be guided by carefully
evaluating the treatment response in these cases.
In conclusion, mechanically harvested products such as wine
and grape juice can be a source of F. tularensis infection and may
cause small epidemics. This has implications for public health, as
outbreaks have to be taken into account in hitherto unknown
epidemiological settings. As a consequence, the diagnosis of
tularemia should be considered in the case of a corresponding
clinical pattern and a history of exposure to the agricultural
processes and products mentioned above. Antibiotic treatment in
tularemia patients can be difﬁcult and prolonged. Current
recommended treatment durations might be too short in some
cases.
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